Related Experiment Video
Updated: May 10, 2025
04:00
A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
Published on: September 7, 2011
66.0K
LncRNAs Regulate Vasculogenic Mimicry in Human Cancers
Eloísa Ibarra-Sierra1, Mercedes Bermúdez2, Carlos Esteban Villegas-Mercado2
1Instituto Estatal de Cancerología "Dr. Arturo Beltrán Ortega", Acapulco Guerrero 39530, Mexico.
Cells
|April 25, 2025
Summary
Long non-coding RNAs (lncRNAs) regulate vasculogenic mimicry (VM) in aggressive cancers. Understanding lncRNA roles in VM offers insights into tumor progression and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Vasculogenic mimicry (VM) is an alternative tumor-feeding mechanism in aggressive cancers.
- Tumor cells form 3D channels for nutrient and oxygen transport, correlating with poor prognosis.
- Long non-coding RNAs (lncRNAs) are key regulators in cancer development and progression.
Purpose of the Study:
- To review the role of lncRNAs in regulating VM in cancer.
- To examine the molecular mechanisms by which lncRNAs influence VM.
- To highlight commonalities in lncRNA-mediated VM functions across cancer types.
Main Methods:
- Literature review of current knowledge on lncRNAs and VM.
- Analysis of molecular mechanisms and cellular functions.
- Identification of commonalities in VM regulation by lncRNAs.
Main Results:
- lncRNAs play critical roles in regulating cancer cell proliferation, apoptosis, angiogenesis, and metastasis.
- Specific lncRNAs are involved in the formation and maintenance of VM channel-like structures.
- Common molecular pathways regulated by lncRNAs in VM have been identified across different cancers.
Conclusions:
- lncRNAs are crucial regulators of vasculogenic mimicry in cancer.
- Further research into lncRNA functions in VM can improve cancer diagnosis and prognosis.
- lncRNAs represent promising targets for novel RNA-based cancer therapies.
More Related Videos
09:03Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
9.7K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
5.9K
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:10Mechanism of Angiogenesis
5.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.0K
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
02:23Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:41Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K